` MDR (Medadvisor Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

MDR
vs
S&P/ASX 300

Over the past 12 months, MDR has underperformed S&P/ASX 300, delivering a return of -73% compared to the S&P/ASX 300's 6% growth.

Stocks Performance
MDR vs S&P/ASX 300

Loading

Performance Gap
MDR vs S&P/ASX 300

Loading
MDR
S&P/ASX 300
Difference

Performance By Year
MDR vs S&P/ASX 300

Loading
MDR
S&P/ASX 300
Add Stock

Competitors Performance
Medadvisor Ltd vs Peers

S&P/ASX 300
MDR
VEEV
PME
DOCS
2413
Add Stock

Medadvisor Ltd
Glance View

Market Cap
48m AUD
Industry
Health Care

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..

MDR Intrinsic Value
0.151 AUD
Undervaluation 42%
Intrinsic Value
Price
Back to Top